ATE238420T1 - Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus - Google Patents

Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus

Info

Publication number
ATE238420T1
ATE238420T1 AT93919473T AT93919473T ATE238420T1 AT E238420 T1 ATE238420 T1 AT E238420T1 AT 93919473 T AT93919473 T AT 93919473T AT 93919473 T AT93919473 T AT 93919473T AT E238420 T1 ATE238420 T1 AT E238420T1
Authority
AT
Austria
Prior art keywords
humanized antibody
antibody against
against human
recombinant humanized
deficiency virus
Prior art date
Application number
AT93919473T
Other languages
English (en)
Inventor
Joseph William Harris
Francis Joseph Carr
Kathryn Lesley Armour
Original Assignee
Nissin Food Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Food Products Ltd filed Critical Nissin Food Products Ltd
Application granted granted Critical
Publication of ATE238420T1 publication Critical patent/ATE238420T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93919473T 1993-08-24 1993-08-24 Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus ATE238420T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1993/001798 WO1995006119A1 (en) 1993-08-24 1993-08-24 Recombinant humanized anti-human immunodeficiency virus antibody

Publications (1)

Publication Number Publication Date
ATE238420T1 true ATE238420T1 (de) 2003-05-15

Family

ID=10729537

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93919473T ATE238420T1 (de) 1993-08-24 1993-08-24 Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus

Country Status (9)

Country Link
US (1) US5607847A (de)
EP (1) EP0714439B1 (de)
JP (1) JP3741221B2 (de)
KR (1) KR100304333B1 (de)
AT (1) ATE238420T1 (de)
AU (1) AU685397B2 (de)
CA (1) CA2170034C (de)
DE (1) DE69332911T2 (de)
WO (1) WO1995006119A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE238420T1 (de) * 1993-08-24 2003-05-15 Nissin Food Products Ltd Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US5843882A (en) 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
CN1157602C (zh) * 1997-09-05 2004-07-14 松下电器产业株式会社 荧光偏振法检测样品的方法及其中使用的试剂
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
DE60221705T2 (de) 2001-03-22 2008-06-05 The United States of America, represented by the Secretary, Dept. of Health and Human Services, the Natl. Institutes of Health, Office of Technology Transfer Glykosylierungsresistente cyanovirine und damit verbundene konjugate, zusammensetzungen, nukleinsäuren, vektoren, wirtszellen, herstellungsverfahren sowie verfahren zur verwendung nichtglykosylierter cyanovirine
FR2844513B1 (fr) * 2002-09-13 2007-08-03 Lab Francais Du Fractionnement Anticorps pour adcc et induisant la production de cytokines.
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5245015A (en) * 1991-04-26 1993-09-14 Tanox Biosystems, Inc. Monoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitro
EP0535154A4 (en) * 1990-06-15 1993-12-01 New York University Heterohybridomas producing human monoclonal antibodies to hiv-1
US5795965A (en) * 1991-04-25 1998-08-18 Chugai Seiyaku Kabushiki Kaisha Reshaped human to human interleukin-6 receptor
WO1993004090A1 (en) * 1991-08-22 1993-03-04 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
AU674539B2 (en) * 1991-08-22 1997-01-02 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
WO1993008216A1 (en) * 1991-10-15 1993-04-29 New York University Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv
ATE238420T1 (de) * 1993-08-24 2003-05-15 Nissin Food Products Ltd Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus

Also Published As

Publication number Publication date
CA2170034C (en) 2005-03-15
JPH09501838A (ja) 1997-02-25
KR100304333B1 (ko) 2001-11-30
AU685397B2 (en) 1998-01-22
DE69332911D1 (de) 2003-05-28
EP0714439B1 (de) 2003-04-23
DE69332911T2 (de) 2003-12-18
US5607847A (en) 1997-03-04
CA2170034A1 (en) 1995-03-02
JP3741221B2 (ja) 2006-02-01
WO1995006119A1 (en) 1995-03-02
EP0714439A1 (de) 1996-06-05
AU4968793A (en) 1995-03-21

Similar Documents

Publication Publication Date Title
ATE238420T1 (de) Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus
DE3853779D1 (de) Hiv-1 neutralisierende monoklonale antikörper.
DE69434499D1 (de) Monoklonale Antikörper und Fv gegen das CD2 Antigen
ATE405679T1 (de) Synthetische humane neutralisierende monoklonale antikörper gegen hiv
ES2067866T3 (es) Reactivos inmunologicos que reaccionan con un epitopo constante del virus inmunodeficiente humano del tipo i (vih-1)gp120 y metodos de utilizacion.
DE69721713D1 (de) Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag)
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE173024T1 (de) In der therapie von einer hiv-1-infektion verwendbare monoklonale antikörper
JPS6485928A (en) Monoclonal antibody and peptide useful for therapy and diagnosis for hiv infection
MC2308A1 (fr) Peptides utilises dans la vaccination et l'induction d'anticorps neutralisant contre le virus de l'immunodeficience humaine
Pietzsch et al. Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity
RU93005284A (ru) Моноклональные антитела линии клеток, фармацевтические композиции, способы лечения, фрагмент антитела
ATE148918T1 (de) Für die co4-bindende domäne von hiv spezifische antikörper
BRPI9709524B8 (pt) processo para a produção de um anticorpo para células t que expressam cd4
SE9000333D0 (sv) Monoklonal antikropp
AU8010791A (en) Hiv monoclonal antibody
DE60215676D1 (de) Gegen ein peptid, das ein kryptisches epitop von gp41 aus hiv-1 nachahmt gerichteter antikörper
ATE201698T1 (de) Immuntherapeutika gegen hiv
PT1368478E (pt) Polipeptido indutor de anticorpos neutralizantes de vih
AU4832097A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
RU94024562A (ru) Антитело, полинуклеотид, клетка, способ получения антитела
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
ES2073287T3 (es) Metodo para el diagnostico in vitro de infecciones con virus hiv-1.
CA2046016A1 (en) Hiv monoclonal antibody
WO1998001570A3 (en) Mutated antibody-dependent infection enhancing domains of hiv

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties